Background: ARTS-II was designed to evaluate the sirolimus-eluting stent (SES) versus
ARTS-I. The objective of this analysis is to assess the safety and efficacy of the SES in …

Objectives: We compared the 5-year outcomes of diabetic patients with multivessel disease
treated with sirolimus-eluting stents (SES), bare-metal stents (BMS), and coronary artery …

Objectives: The purpose of this study was to assess the 3-year outcome of coronary artery
bypass graft surgery (CABG) and percutaneous coronary intervention (PCI) using sirolimus …

INTRODUCTION AND OBJECTIVES: Since the introduction of drug-eluting stents, the
optimum revascularization strategy in diabetic patients with multivessel coronary disease …

Aims The aim of this article was to compare rates of all-cause death at 10 years following
coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) in …

Background Studies comparing coronary artery bypass grafting (CABG) with drug‐eluting
stent (DES) for the treatment of diabetic patients with multivessel disease are relatively …

Objective There is a paucity of data on the impact of complete revascularisation (CR)
following percutaneous coronary intervention (PCI) among patients with diabetes with …

Background The study compares five-year clinical outcomes of CABG vs PCI in a real world
population of diabetic patients with multivessel coronary disease since it is not clear whether …

Background: In diabetic patients with multivessel coronary artery disease (CAD), the survival
difference between coronary artery bypass graft (CABG) surgery and percutaneous coronary …

Background Our aims were to compare coronary artery bypass grafting (CABG) and stenting
for the treatment of diabetic patients with multivessel coronary disease enrolled in the …